Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001117480-24-000035
Filing Date
2024-11-07
Accepted
2024-11-07 07:28:26
Documents
53
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cmrx-20240930.htm   iXBRL 10-Q 1211326
2 EX-10.1 a20240930cmrxex-101nonxemp.htm EX-10.1 15570
3 EX-31.1 a20240930cmrxex-311.htm EX-31.1 9557
4 EX-31.2 a20240930cmrxex-312.htm EX-31.2 9737
5 EX-32.1 a20240930cmrxex-321.htm EX-32.1 6973
6 EX-32.2 a20240930cmrxex-322.htm EX-32.2 6699
  Complete submission text file 0001117480-24-000035.txt   5347438

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cmrx-20240930.xsd EX-101.SCH 28346
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cmrx-20240930_cal.xml EX-101.CAL 57704
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cmrx-20240930_def.xml EX-101.DEF 140893
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cmrx-20240930_lab.xml EX-101.LAB 466150
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cmrx-20240930_pre.xml EX-101.PRE 301768
55 EXTRACTED XBRL INSTANCE DOCUMENT cmrx-20240930_htm.xml XML 665362
Mailing Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713
Business Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713 919.806.1074
CHIMERIX INC (Filer) CIK: 0001117480 (see all company filings)

EIN.: 330903395 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35867 | Film No.: 241433176
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)